Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Immune Characterization of Ibrutinib Therapy Following Allohct That Provides GVL Benefit without Gvhd Sahaf, B., Ryan, C. E., Rezvani, A., Nakasone, H., Otani, J., Coutre, S., Lowsky, R., Negrin, R., Miklos, D. B. ELSEVIER SCIENCE INC. 2016: S412
View details for DOI 10.1016/j.bbmt.2015.11.945
View details for Web of Science ID 000370910300620